indeloxazine has been researched along with Dementia in 5 studies
indeloxazine: RN given refers to parent cpd without isomeric designation
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Plasma concentrations of cerebral metabolic activating drugs (bifemelane, indeloxazine and propentofylline) were studied in 68 patients (male 25, female 43) with dementia or other organic brain diseases." | 3.69 | A preliminary study on plasma concentrations of bifemelane, indeloxazine and propentofylline in aged patients with organic brain disorders. ( Arai, H; Inoue, R; Kimura, M; Minami, M; Noguchi, I; Suzuki, T; Takahashi, T, 1995) |
| "Event-related potentials, measured eight times in a patient in the early stages of dementia, demonstrated that clinical symptoms, especially loss of motivation, improved coincidentally with a shortening of reaction time, N1 latency, and P3 latency during nicergoline medication among three nootropics prescribed." | 3.68 | Shortening of N1 and P3 latencies in event-related potentials observed coincidentally with clinical improvement during nootropic medication in a demented patient: specific effect of nicergoline. ( Fukuda, M; Hata, A; Hayashida, S; Hiramatsu, K; Honda, H; Honda, M; Iwanami, A; Nakagome, K; Niwa, S; Sasaki, T, 1992) |
| "Effects of indeloxazine, a new compound which has been though to block reuptake of serotonin and noradrenaline, on cerebrospinal fluid monoamine metabolites were evaluated in 11 patients with dementia." | 3.67 | Effects of indeloxazine, (+)-2-[inden-7-yloxy)methyl]morpholine hydrochloride on cerebrospinal fluid monoamine metabolites. ( Fukuzawa, N; Mizuno, Y; Shimabukuro, T, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Minami, M | 1 |
| Arai, H | 1 |
| Takahashi, T | 2 |
| Kimura, M | 1 |
| Noguchi, I | 1 |
| Suzuki, T | 1 |
| Inoue, R | 1 |
| Otomo, E | 1 |
| Fukuda, M | 1 |
| Hiramatsu, K | 1 |
| Honda, M | 1 |
| Niwa, S | 1 |
| Sasaki, T | 1 |
| Hata, A | 1 |
| Nakagome, K | 1 |
| Iwanami, A | 1 |
| Honda, H | 1 |
| Hayashida, S | 1 |
| Kataoka, K | 1 |
| Mizuno, Y | 1 |
| Shimabukuro, T | 1 |
| Fukuzawa, N | 1 |
1 review available for indeloxazine and Dementia
| Article | Year |
|---|---|
[Cerebral circulatory improvers and metabolic activators].
Topics: Aged; Antidepressive Agents; Benzoquinones; Brain; Cerebrovascular Circulation; Cerebrovascular Diso | 1994 |
4 other studies available for indeloxazine and Dementia
| Article | Year |
|---|---|
A preliminary study on plasma concentrations of bifemelane, indeloxazine and propentofylline in aged patients with organic brain disorders.
Topics: Aged; Antidepressive Agents; Benzhydryl Compounds; Dementia; Female; Humans; Male; Morpholines; Xant | 1995 |
Shortening of N1 and P3 latencies in event-related potentials observed coincidentally with clinical improvement during nootropic medication in a demented patient: specific effect of nicergoline.
Topics: Aged; Benzhydryl Compounds; Dementia; Electroencephalography; Evoked Potentials; Humans; Male; Morph | 1992 |
Influence of indeloxazine hydrochloride upon photic driving responses elicited by flickering dot pattern and red flicker stimuli in elderly patients.
Topics: Aged; Antidepressive Agents; Arousal; Cerebral Cortex; Color Perception; Dementia; Electroencephalog | 1990 |
Effects of indeloxazine, (+)-2-[inden-7-yloxy)methyl]morpholine hydrochloride on cerebrospinal fluid monoamine metabolites.
Topics: Adult; Aged; Aged, 80 and over; Dementia; Dopamine; Female; Glycols; Homovanillic Acid; Humans; Hydr | 1988 |